CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company’s lead development candidate is ...
The CERo Therapeutics Holdings, Inc. stock price fell by -9.60% on the last day (Thursday, 17th Sep 2026) from $0.0125 to $0.0113. During the last trading day the stock fluctuated 25.00% from a day ...
As of 12:37:44 PM EDT. Market Open.
CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results